Burden of isolation for multidrug-resistant organisms in a tertiary public hospital in Southern Brazil

Published:December 03, 2014DOI:


      • Isolation precautions demand spending of a large amount of resources.
      • Multidrug-resistant gram-negative bacteria are the biggest challenge in our setting.
      • Benefits of screening and isolation must be balanced against resource utilization.
      We aimed to describe the use of isolation beds between September 2011 and August 2013 at a tertiary hospital located in Southern Brazil. The main cause for isolation was gram-negative carbapenem-resistant bacteria. Huge costs were associated with isolation practices. Considering the high burden on the isolation ward, practice of surveillance cultures and contact isolation should be balanced with other infection control practices.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Siegel J.D.
        • Rhinehart E.
        • Jackson M.
        • Chiarello L.
        2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings.
        Am J Infect Control. 2007; 35: S65-S164
        • Carvalho-Assef A.P.
        • Pereira P.S.
        • Albano R.M.
        • Beriao G.C.
        • Chagas T.P.
        • Timm L.N.
        • et al.
        Isolation of NDM-producing Providencia rettgeri in Brazil.
        J Antimicrob Chemother. 2013; 68: 2956-2957
        • Martins A.F.
        • Kuchenbecker R.
        • Sukiennik T.
        • Boff R.
        • Reiter K.C.
        • Lutz L.
        • et al.
        Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.
        Infection. 2009; 37: 474-476
        • Rossi F.
        The challenges of antimicrobial resistance in Brazil.
        Clin Infect Dis. 2011; 52: 1138-1143
        • Sampaio J.L.
        • Ribeiro V.B.
        • Campos J.C.
        • Rozales F.P.
        • Magagnin C.M.
        • Falci D.R.
        • et al.
        Detection of OXA-370, an OXA-48-Related class D beta-lactamase, in Enterobacter hormaechei from Brazil.
        Antimicrob Agents Chemother. 2014; 58: 3566-3567
        • Muto C.A.
        • Jernigan J.A.
        • Ostrowsky B.E.
        • Richet H.M.
        • Jarvis W.R.
        • Boyce J.M.
        • et al.
        SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.
        Infect Control Hosp Epidemiol. 2003; 24: 362-386
        • Siegel J.D.
        • Rhinehart E.
        • Jackson M.
        • Chiarello L.
        Management of multidrug-resistant organisms in health care settings, 2006.
        Am J Infect Control. 2007; 35: S165-S193
        • Abad C.
        • Fearday A.
        • Safdar N.
        Adverse effects of isolation in hospitalised patients: a systematic review.
        J Hosp Infect. 2010; 76: 97-102
        • Zahar J.R.
        • Garrouste-Orgeas M.
        • Vesin A.
        • Schwebel C.
        • Bonadona A.
        • Philippart F.
        • et al.
        Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
        Intensive Care Med. 2013; 39: 2153-2160
        • Derde L.P.
        • Cooper B.S.
        • Goossens H.
        • Malhotra-Kumar S.
        • Willems R.J.
        • Gniadkowski M.
        • et al.
        Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.
        Lancet Infect Dis. 2014; 14: 31-39